跳至主要内容
临床试验/JPRN-UMIN000034673
JPRN-UMIN000034673已完成未知

Exploration of predictive factors for prognosis of community-onset pneumonia in adults: a multicenter prospective observational study - Exploration of predictive factors for prognosis of community-onset pneumonia in adults

agasaki University0 个研究点目标入组 2,103 人开始时间: 2018年11月29日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,103

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • - Any subject who is transferred to a participating medical institution after already being hospitalized for 48 hours or more at any other hospital. - Hospital acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more) - Previous enrollment in this study within the past 30 days. - Any subject who has received effective antibacterial drug therapy for the current pneumonia and improvement is observed (Note: subjects who have received antibacterial agents for a continuous duration of more than 3 days for the current pneumonia and considered as treatment failure based on the investigators judgment are allowed). - Any subject who has received azithromycin during the previous 7 days. - Any subject who has a concurrent condition or infection that, in the investigators judgment, would preclude evaluation of therapeutic response (e.g. advanced cancer, primary or metastatic lung cancer, severe heart failure, cystic fibrosis, AIDS, pneumocystis pneumonia, active tuberculosis) - Any subject who has a history or current condition, therapy, laboratory abnormality, or other circumstance that, in the opinion of the investigator, might confound the results of the study or interfere with the participation for the full duration of the study. Note: Subjects who are anticipated to be treated with any of the following medications during the course of study are allowed: long-term low-dose macrolide therapy without change of dosage, intravenous/oral/inhaled prednisolone (<10 mg/day) without change of dosage, immunosuppressive agents without change of dosage, and antipyretic analgesics taken as a one-shot-medicine.

研究者

发起方
agasaki University

相似试验

Exploration of predictive factors for prognosis of... | 临床试验